Updated: Mar 31, 2022
TBnet webinar today: TB advocacy: patients and public involvement in research.
This webinar is our contribution to the World TB Day and is organized by Jess Potter, the TBnet Advocacy Lead!
Read more about it and join the webinar here: https://www.tbnet.eu/post/tbnet-webinar-march-2022
A new TBnet study is published!
Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.
Congrats to the authors: Simone Tunesi, Damien Le Dû, Gina Gualano, Joan-Pau Millet, Aliaksandr Skrahin, Graham Bothamley, Xavier Casas, Delia Goletti, Christoph Lange, Maria Musso, Fabrizio Palmieri, Valérie Pourcher, Christophe Rioux, Alena Skrahina, Nicolas Veziris, Dzmitry Viatushka, Mathilde Jachym-Fréchet Lorenzo Guglielmetti.
“In our multicentre, retrospective cohort study, concomitant HCV and MDR/RR-TB treatment was effective and well-tolerated. DAA treatment led to achieve undetectable HCV-RNA and sustained virological response for all patients with available data. Similarly, treatment success was achieved for 91% of patients who completed MDR/RR-TB treatment”
Below is URL providing 50 days' free access to the article. Anyone clicking on this link before May 09, 2022 will be taken directly to the latest version of the article, which they are welcome to read or download. No sign-up, registration or fees are required.
UNITE4TB consortium published a review – TBnet colleagues among the authors!
Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.
Congrats to the authors: Jan Heyckendorf, Sophia B. Georghiou, Nicole Frahm, Norbert Heinrich, Irina Kontsevaya, Maja Reimann, David Holtzman, Marjorie Imperial, Daniela M. Cirillo Stephen H. Gillespie, Morten Ruhwald, on behalf of the UNITE4TB Consortium.
TBnet centers in different countries host Ukrainian colleagues + other Ukraine-related news
As a response to war in Ukraine, several institutions/labs involved in TBnet opened their doors to Ukrainian colleagues. One of the leading host organizations in this matter is Serveis Clinics, Barcelona. They used INNOVA4TB funding to host five colleagues from Ukraine. http://serveisclinics.com/en/
Ukrainian colleagues also came to the universities and hospitals in Sweden, Germany and other countries.
Additionally: thanks for supporting the ptbnet fundraising for Ukrainian paediatric TB patients and colleagues. Over 13 000 pounds collected! https://www.justgiving.com/crowdfunding/ptbnet-ukraine-appeal
Additionally: Jess Potter together with Tom Wingfield have written about their concerns relating to multi-drug resistant TB and the impact of war. Very useful reading! https://theconversation.com/russias-invasion-of-ukraine-poses-a-threat-to-the-control-of-drug-resistant-tb-in-europe-and-the-world-179126
TBnet Academy 2022, Georgia, updates
Dear colleagues and friends! Thank you so much for applying to TBnet Academy 2022 in Georgia! We carefully continue to prepare the event. We have received a lot of wonderful applications and it was hard to choose! However, by now the selection of participants has been finalized. Those who best matched the selection criteria will soon receive the invitations.
We closely monitor the situation in Georgia and there will be updates as for the TBnet Academy in complex geopolitical settings.